The Turkish Aerospace Industries (TAI) is conducting two unmanned aerial vehicle (UAV) projects along with three plane and six helicopter projects, including a national combat aircraft (MMU), the chairman said.
Saying the most important project is the MMU, Temel Kotil told Anadolu Agency that the project requires around 6,000 staff, half of them from TAI and the rest from other contributor firms.
Kotil noted that the fifth-generation aircraft has only one pilot, while artificial intelligence serves as the second pilot, and added that the MMU will have this feature.
The MMU's engine will start in 2023 and the plane will fly in 2025, then it will be delivered to the Turkish Air Forces, he underlined.
The engine has been developed by Turkey's indigenous engine production company TR Motor, a joint company of TAI and another Turkish defense firm SSTEK, Kotil said, stressing that support from other companies is required to develop peripheral and sub-components of the engine.
The landing gears will be jointly made by an Italian and a Turkish company, Turkey will own its intellectual rights, and climate systems will be produced in Turkey, he said, and added that Turkey must completely own the plane to make it "national."
Competitors are aware that Turkey and TAI are strong players, he underlined, saying: "If they gave the license of the F-35, we would make two units per month as TAI. The important thing is the license, the intellectual property rights. Otherwise, we have the capability to make the F-35 right now.
"We have been trying to make the MMU as local as possible from the very beginning. ... Everything [all its parts] must be indigenous and national to sell it to friendly countries. We have no choice but to spread this [process] over a span of time, including the engine [production]," added Kotil.
* Writing by Gokhan Ergocun in IstanbulAnadolu Agency website contains only a portion of the news stories offered to subscribers in the AA News Broadcasting System (HAS), and in summarized form. Please contact us for subscription options.